Parametrica Management LTD Acadia Pharmaceuticals Inc Transaction History

Parametrica Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $481,542 - $755,881	-30,516 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $119,775 - $169,291	6,174 Added 25.36%	30,516 $744,000
Q1 2021 May 14, 2021	BUY	$25.02 - $54.99 $609,036 - $1.34 Million	24,342 New	24,342 $627,000
Q2 2019 Aug 13, 2019	SELL	$23.32 - $28.12 $190,244 - $229,402	-8,158 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$16.17 - $27.38 $131,914 - $223,366	8,158 New	8,158 $219,000

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.